MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
Publication Delays Impact Careers of Early-Career Researchers
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
Trump Science Publishing Critique: Analyzing Political Interference and Metho...
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
Defunding Scientific Research: Implications and Misconceptions in GawandeR...
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework
Advancing Pediatric Leukemia Trial: Precision Medicine and Transformative Res...
Environmental Exposures and Pediatric Thyroid Cancer Risk: Key Findings from ...